Director, Managing director Inserm Transfert Initiative

François Thomas has more than 25 years of experience in the life sciences sector. Before becoming Manager Partner at Inserm Transfert Initiative in 2014, he held management positions at Ipsen (VP Clinical Development and CMO) and Genset (VP Licensing and Pharmacogenomics). In 2002, François became Venture Partner at Atlas Venture and in 2006 he was responsible for healthcare corporate finance at Bryan Garnier. Most recently, he was CEO of Cytheris, a private biotech company. François has been a independent board member of several biotech companies such as Eurogentec, YM Biosciences and Gamamabs, as well as representative of Atlas and ITI in over 20 boards. In addition, in 1995 François founded a consultancy company called Bioserve Ltd. François is medical oncologist, a former assistant professor at the Gustave Roussy Institute, and holds a Ph. D in molecular oncology and an MBA from MIT (Boston).